Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Treasury Shares (2020 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Treasury Shares for 6 consecutive years, with $796498.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 24.67% to $796498.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $796498.0 through Dec 2025, up 24.67% year-over-year, with the annual reading at $796498.0 for FY2025, 24.67% up from the prior year.
  • Treasury Shares hit $796498.0 in Q4 2025 for Harmony Biosciences Holdings, roughly flat from $799587.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $944252.0 in Q1 2025 to a low of $30000.0 in Q2 2023.
  • Historically, Treasury Shares has averaged $335469.4 across 5 years, with a median of $60000.0 in 2021.
  • Biggest five-year swings in Treasury Shares: crashed 50.0% in 2023 and later surged 2487.83% in 2024.
  • Year by year, Treasury Shares stood at $60000.0 in 2021, then changed by 0.0% to $60000.0 in 2022, then soared by 450.0% to $330000.0 in 2023, then surged by 93.61% to $638900.0 in 2024, then increased by 24.67% to $796498.0 in 2025.
  • Business Quant data shows Treasury Shares for HRMY at $796498.0 in Q4 2025, $799587.0 in Q3 2025, and $847264.0 in Q2 2025.